Replies to post #3436 on Biotech Values

[DewDiligence]

>> There's loopholes that help the generic companies, such as first to file status, encouraging (often) frivilous patent challenges for the reward of being "first to file." <<

Absolutely correct; that’s an area badly in need of reform:

#msg-3443385

Dew